Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Beth Sherrill
Vice President, Biostatistics
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Jonathan Graham
Director, Health Economics
Kelly Hollis
Vice President, Surveys and Observational Studies
Ryan Ziemiecki
Senior Statistician
Christopher Graham
Senior Director, Health Economics
Colleen Castro
Associate, Market Access and Outcomes Strategy
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Sean Candrilli
Head, Health Economics
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Laurel Trantham
Associate Director, Health Economics
Christopher Knight
Senior Director, Health Economics
Kenneth Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Michele Wilson
Director, Health Economics
Jessica Costello
Writer, Market Access and Outcomes Strategy
Jianmin Wang
Director, Biostatistics, US
Juliana Meyers
Director, Health Economics
Marci Clark
Director, Patient-Centered Outcomes Assessment
Sorrel Wolowacz
Head, European Health Economics
Katherine Houghton
Associate Director, Health Economics
James Kaye
Senior Director, Epidemiology
Xiaolei Zhou
Director, Biostatistics, US
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Katherine Hicks
Director, Health Economics
Lori McLeod
Head, Psychometrics & Executive Director, Patient-Centered Outcomes Assessment
Shahnaz Khan
Senior Director, Market Access and Outcomes Strategy
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Mark Price
Senior Director, Surveys and Observational Studies
Susan Hogue
Head, Value Insight and Access Strategy
Costel Chirila
Director, Biostatistics
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Dawn Odom
Global Head, Biostatistics
Ewa Rupniewska
Senior Associate, Market Access and Outcomes Strategy
Christine Poulos
Senior Research Economist
Keith Davis
Senior Director, Health Economics
Bintu Sherif
Senior Statistician
Anne Heyes
Head, Market Access and Outcomes Strategy, Europe
Alicia Gilsenan
Senior Director, Epidemiology
Donald Stull
Head, Data Analytics and Design Strategy
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Stephanie Barrows
Senior Director, Market Access and Outcomes Strategy
Jin Yang
Sr. Associate, Market Access and Outcomes Strategy
Isobel Pearson
Director, Health Economics
Carol Mansfield
Senior Research Economist
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Will Herring
Director, Health Economics
Lia Gutierrez
Director, Epidemiology
Marco Boeri
Senior Research Economist
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Annete Njue
Director, Market Access and Outcomes Strategy
Joan Fortuny
Director, Epidemiology

Selected Recent Oncology Publications